• Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals


1.6750 AUD 0.0050 0.30%

As of 02:11:00 ET on 04/17/2014.

Snapshot for Acrux Ltd (ACR)

Open: 1.6800 Day's Range: 1.6450 - 1.6850 Volume: 1,594,384
Previous Close: 1.6800 52wk Range: 1.6450 - 3.9012 1-Yr Rtn: -48.54%

Stock Chart for ACR

No chart data available.
  • ACR:AU 1.6750
  • 1D
  • 1M
  • 1Y
Interactive ACR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ACR

Current P/E Ratio (ttm) 9.3733
Estimated P/E(06/2014) 7.9384
Relative P/E vs. AS51 0.4772
Earnings Per Share (AUD) (ttm) 0.1787
Est. EPS (AUD) (06/2014) 0.2110
Est. PEG Ratio -
Market Cap (M AUD) 278.92
Shares Outstanding (M) 166.52
30 Day Average Volume 1,384,408
Price/Book (mrq) 4.7550
Price/Sale (ttm) 5.0626
Dividend Indicated Gross Yield 4.78%
Cash Dividend (AUD) 0.1200
Dividend Ex-Date 02/25/2014
5 Year Dividend Growth -
Next Earnings Announcement 08/27/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ACR

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for ACR

Acrux Limited is a specialty pharmaceutical company that develops a range of healthcare products for the global market. The Company develops transdermal drug delivery systems. The Company's products include hormone products for women's health, anti-aging skin care and haircare products as well as veterinary pharmaceutical products. The company is a Pooled Development Fund.

Ross DobinsonChairman/FounderTony Di PietroCFO/Secretary
Clive BlowerCOO/Chief Technical OfficerNina WebsterDirector:Commercial
More Company Profile & Key Executives for ACR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil